AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 27929709
Drug: Buprenorphine transdermal
RxNorm normalized name: Buprenorphine Transdermal System
DrugBank: Buprenorphine (DB00921)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Buprenorphine transdermal system (BTDS) and active controls (oxycodone/acetaminophen [OXY/APAP] and hydrocodone/acetaminophen [HCD/APAP])
Trial: 18831530
Drug: Istradefylline 20
RxNorm normalized name: istradefylline 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Istradefylline 20 mg once daily
Trial: 11205194
Drug: Atorvastatin 80
RxNorm normalized name: atorvastatin 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin 80 mg daily for 4 months
Trial: 7821060
Drug: Low-dose radiation
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose radiation therapy (5 fractions of 2 Gy each)
Trial: 7821060
Drug: High-dose radiation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose radiation therapy (10 fractions of 2 Gy each)
Trial: 8511308
Drug: Nonsteroidal antiinflammatory
RxNorm normalized name: Arthriten Inflammatory Pain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonsteroidal antiinflammatory drug (NSAID) use
Trial: 8511308
Drug: High RT
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High RT dose with short duration (< or = 9 days)
Trial: 22672081
Drug: LM25 therapy
RxNorm normalized name: tetracycline
DrugBank: Tetracycline (DB00759)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: LM25 therapy (25% insulin lispro, 75% insulin lispro protamine suspension)
Trial: 22672081
Drug: Glargine +
RxNorm normalized name: Insulin Glargine
DrugBank: Insulin glargine (DB00047)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Glargine + insulin lispro therapy
Trial: 18772509
Drug: Simvastatin combined
RxNorm normalized name: Simvastatin
DrugBank: Simvastatin (DB00641)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Simvastatin combined with routine treatment (beta receptor blocker, calcium-channel blocker, long active nitrate)
Trial: 18772509
Drug: Simvastatin combined
RxNorm normalized name: Simvastatin
DrugBank: Simvastatin (DB00641)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Simvastatin combined with routine treatment
Trial: 18772509
Drug: Routine treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine treatment (beta receptor blocker, calcium-channel blocker, long active nitrate)
Trial: 15970103
Drug: Verapamil-procaine compound
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verapamil-procaine compound (V-P)
Trial: 12575474
Drug: 800 mg
RxNorm normalized name: bran 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 800 mg S-adenosyl-L-methionine (SAMe) administered intravenously
Trial: 10597810
Drug: Bilateral injections
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bilateral injections of 2% lidocaine solution without epinephrine into the paraglottic space containing the ibSLN
Trial: 273801
Drug: ALICE live
RxNorm normalized name: fecal microbiota, live Enema [Rebyota]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ALICE live virus intra-nasal vaccine
Trial: 31387390
Drug: Dog-assisted therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dog-assisted therapy intervention (50-min session per week for 9 months)
Trial: 27696447
Drug: INCS daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: INCS daily (fluticasone propionate)
Trial: 3314613
Drug: Oral diltiazem
RxNorm normalized name: diltiazem Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral diltiazem 120 to 180 mg
Trial: 29516704
Drug: 0.5 mcg/kg/h
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mcg/kg/h dexmedetomidine in addition to half dose of opioids and benzodiazepines (D-CASEs)
Trial: 29516704
Drug: Standard dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard dose opioids and benzodiazepines (CONTROLs)
Trial: 20859892
Drug: Intravenous hydration
RxNorm normalized name: Chloral Hydrate
DrugBank: Chloral hydrate (DB01563)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous hydration with isotonic solution (0.9% NaCl)
Trial: 20859892
Drug: Oral hydration
RxNorm normalized name: terpin hydrate Oral Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral hydration with mineral water
Trial: 12844139
Drug: Anakinra (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anakinra (100 mg) administered subcutaneously to subjects with severely impaired renal function
Trial: 12844139
Drug: Anakinra (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anakinra (100 mg) administered subcutaneously to subjects with end-stage renal disease
Trial: 8595479
Drug: Physostigmine infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physostigmine infusion
Trial: 10899358
Drug: Placebo infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo infusion of saline
Trial: 8667466
Drug: Short infusion
RxNorm normalized name: short ragweed pollen extract Sublingual Tablet [Ragwitek]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short infusion regimen of pralidoxime (4 mg/kg over 15 minutes followed by 3.2 mg/kg/h for 3.75 h)
Trial: 8280545
Drug: Sublingual buprenorphine
RxNorm normalized name: buprenorphine Sublingual Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual buprenorphine 0.2 mg
Trial: 20186889
Drug: TEP (totally
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TEP (totally extraperitoneal patch)
Trial: 11594447
Drug: Reboxetine 4
RxNorm normalized name: reboxetine 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reboxetine 4 mg twice daily for 14 days
Trial: 11157143
Drug: IL‐1Ra 150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IL‐1Ra 150 mg/day
Trial: 16777649
Drug: Cognitive Stimulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Stimulation Therapy (CST)
Trial: 22914584
Drug: Primary immunization
RxNorm normalized name: Immune Globulin
DrugBank: Human immunoglobulin G (DB00028)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Primary immunization with recombinant hepatitis B vaccine (Group 1, 5 years post-vaccination)
Trial: 20683930
Drug: Colesevelam (1875
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Colesevelam (1875 mg twice daily for 3 weeks)
Trial: 20683930
Drug: Placebo (identical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (identical to colesevelam, twice daily for 3 weeks)
Trial: 18000709
Drug: Propofol 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol 0.5 mg/kg plus dexamethasone 8 mg
Trial: 18000709
Drug: Propofol 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol 0.5 mg/kg combined with dexamethasone 8 mg
Trial: 14578911
Drug: BILN 2061,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BILN 2061, a small molecule NS3 protease inhibitor administered orally for 2 days
Trial: 4061965
Drug: Pyridostigmine (sustained-release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pyridostigmine (sustained-release form)
Trial: 29895931
Drug: Weight-based (WB)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weight-based (WB) plerixafor 0.24 mg/kg
Trial: 29895931
Drug: Fixed-dose (FD)
RxNorm normalized name: Humalog Mix
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed-dose (FD) plerixafor 20 mg
Trial: 24359044
Drug: 1,000 mg
RxNorm normalized name: bran 1,000 mg ORAL WAFER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1,000 mg of paracetamol via intravenous infusion (Group II)
Trial: 12122552
Drug: 40 g
RxNorm normalized name: PEG-40 GLYCERYL STEARATE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 g lycasin HBC
Trial: 12122552
Drug: 40 g
RxNorm normalized name: PEG-40 GLYCERYL STEARATE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 g isomalt
Trial: 12122552
Drug: 25 g
RxNorm normalized name: AndroGel 1.25 g Packets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 g isomalt
Trial: 12122552
Drug: 25 g
RxNorm normalized name: AndroGel 1.25 g Packets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 g lycasin HBC
Trial: 1693733
Drug: Felodipine ER
RxNorm normalized name: Felodipine ER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Felodipine ER tablets 10 mg once daily (n = 50)
Trial: 1693733
Drug: Plain tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plain tablets 5 mg twice daily (n = 52)
Trial: 582722
Drug: i.v. cefazedone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.v. cefazedone 500 mg
Trial: 582722
Drug: i.v. cefazedone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.v. cefazedone 1000 mg
Trial: 582722
Drug: i.m. cefazedone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.m. cefazedone 500 mg
Trial: 582722
Drug: cefazolin 1000
RxNorm normalized name: cefazolin 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: cefazolin 1000 mg
Trial: 582722
Drug: cefazolin 500
RxNorm normalized name: cefazolin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: cefazolin 500 mg
Trial: 26690199
Drug: baseline HIV-1
RxNorm normalized name: petrolatum 1 MG/MG [Vaseline]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: baseline HIV-1 RNA >100,000 copies/mL
Trial: 21147813
Drug: Relaxation training
RxNorm normalized name: Relax-DS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Relaxation training according to Yoga In Daily Life(®) system
Trial: 18310964
Drug: delapril 30
RxNorm normalized name: Delapril
DrugBank: Delapril (DB13312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: delapril 30 mg/manidipine 10 mg combination
Trial: 18310964
Drug: olmesartan 20
RxNorm normalized name: olmesartan 20 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: olmesartan 20 mg/HCTZ 12.5 mg combination
Trial: 17518172
Drug: Continuous infusion
RxNorm normalized name: insulin pump cartridge,continuous infusion,BT and controller SUBCUT EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous infusion of remifentanil plus morphine and nonsteroidal anti-inflammatory drugs
Trial: 19799882
Drug: Acamprosate (1998
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acamprosate (1998 mg/day)
Trial: 17989696
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (inhaled oxygen placebo only)
Trial: 19841125
Drug: Inhaled nitric
RxNorm normalized name: nitric oxide Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled nitric oxide (iNO) therapy
Trial: 9895043
Drug: Cisapride 10
RxNorm normalized name: cisapride 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisapride 10 mg t.i.d. for 3 days
Trial: 9166505
Drug: 1.0 mg
RxNorm normalized name: HYDROCORTISONE BUTYRATE 1.0 mg in 1 g TOPICAL CREAM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.0 mg oral granisetron HCI twice a day for 7 days
Trial: 1901104
Drug: Intravenous medium-chain
RxNorm normalized name: Medium-Chain Triglycerides
DrugBank: Medium-chain triglycerides (DB13959)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous medium-chain triglycerides (MCT)
Trial: 1901104
Drug: Intravenous long-chain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous long-chain triglycerides (LCT)
Trial: 30922814
Drug: CNSA-001 (sepiapterin)
RxNorm normalized name: Sepiapterin
DrugBank: Sepiapterin (DB16326)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CNSA-001 (sepiapterin) 5, 20 or 60 mg/kg (repeat daily dosing)
Trial: 23444761
Drug: Oral misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral misoprostol (400 microg every four hours, up to three doses)
Trial: 23444761
Drug: Vaginal misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vaginal misoprostol (400 microg every four hours, up to three doses)
Trial: 23444761
Drug: Vaginal misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vaginal misoprostol (600 microg primary dosage)
Trial: 23444761
Drug: Vaginal misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vaginal misoprostol (600 microg primary dosage) and continuation of oral dose
Trial: 19006526
Drug: Organized weekly
RxNorm normalized name: Organic germanium
DrugBank: Propagermanium (DB17608)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Organized weekly exercise for 13 weeks
Trial: 14501621
Drug: Mosapride 60
RxNorm normalized name: mosapride
DrugBank: Mosapride (DB11675)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mosapride 60 mg twice daily
Trial: 14501621
Drug: Mosapride 30
RxNorm normalized name: mosapride
DrugBank: Mosapride (DB11675)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mosapride 30 mg three times daily
Trial: 10463897
Drug: Cisapride 20
RxNorm normalized name: cisapride 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisapride 20 mg twice daily
Trial: 3421202
Drug: 272 g
RxNorm normalized name: SODIUM FLUORIDE 0.0272 g in 1 g DENTAL AEROSOL, FOAM [PCXX LIME APF F]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 272 g cooked carrots
Trial: 22686292
Drug: Simvastatin 40
RxNorm normalized name: simvastatin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin 40 mg once daily for 6 months
Trial: 21654733
Drug: CC/CT genotypes
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CC/CT genotypes of the FKBP5 gene SNP rs1360780
Trial: 18985059
Drug: Psyllium (3.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psyllium (3.0 to 20.4 g per day)
Trial: 12761949
Drug: Regional intra-arterial
RxNorm normalized name: methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Regional intra-arterial chemotherapy (IACT)
Trial: 12761949
Drug: Systemic chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Systemic chemotherapy (SCT)
Trial: 30170329
Drug: Pregabalin (75-600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pregabalin (75-600 mg/day)
Trial: 26931509
Drug: Energy drink
RxNorm normalized name: Boost Energy Drink
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Energy drink (2 mg caffeine per kg body weight; low dose)
Trial: 26931509
Drug: Energy drink
RxNorm normalized name: Boost Energy Drink
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Energy drink (3 mg caffeine per kg body weight; medium dose)
Trial: 26931509
Drug: Coffee (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Coffee (2 mg caffeine per kg body weight)
Trial: 26931509
Drug: 250 ml
RxNorm normalized name: TPN Bag 250 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 ml water
Trial: 16087057
Drug: No treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No treatment (n = 25)
Trial: 18653326
Drug: Imatinib mesylate
RxNorm normalized name: Imatinib Mesylate
DrugBank: Imatinib (DB00619)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Imatinib mesylate (two doses)
Trial: 12924702
Drug: Aprotinin (240
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aprotinin (240 mg/m2 administered intravenously over 20 minutes, followed by infusions of 56 mg/m2/hr)
Trial: 2689183
Drug: Clonazepam (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonazepam (2 mg)
Trial: 1353708
Drug: Esmolol (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esmolol (500 micrograms.kg‐1 i.v. bolus followed by 150‐300 micrograms.kg‐1.min‐1 maintenance infusion)
Trial: 1353708
Drug: Labetalol (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Labetalol (5 mg i.v. bolus followed by 5 mg increments as needed up to a maximum of 1 mg.kg‐1)
Trial: 6337524
Drug: Extradural diamorphine
RxNorm normalized name: Diamorphine
DrugBank: Diamorphine (DB01452)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extradural diamorphine 0.1 mg/kg
Trial: 6337524
Drug: Intramuscular diamorphine
RxNorm normalized name: Diamorphine
DrugBank: Diamorphine (DB01452)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular diamorphine 0.1 mg/kg
Trial: 29475804
Drug: Tenofovir alafenamide
RxNorm normalized name: Tenofovir Alafenamide
DrugBank: Tenofovir alafenamide (DB09299)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Tenofovir alafenamide (10 mg or 25 mg) plus emtricitabine (200 mg)
Trial: 29475804
Drug: Abacavir (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Abacavir (600 mg) plus lamivudine (300 mg)
Trial: 17805089
Drug: Quercetin (1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quercetin (1000 mg.d(‐1))
Trial: 11133794
Drug: IVIg (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IVIg (500 mg/kg/day for 5 consecutive days, once a month for 3 months)
Trial: 7518629
Drug: 0.0005% iloprost
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.0005% iloprost solution
Trial: 30980539
Drug: Metformin at
RxNorm normalized name: AT 10
DrugBank: Dihydrotachysterol (DB01070)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin at baseline
Trial: 30980539
Drug: Metformin during
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin during concomitant radiochemotherapy (TMZ/RT)
Trial: 30980539
Drug: Metformin monotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin monotherapy at baseline
Trial: 30980539
Drug: Metformin monotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin monotherapy during TMZ/RT
Trial: 14635083
Drug: Palonosetron 0.25
RxNorm normalized name: palonosetron 0.25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Palonosetron 0.25 mg
Trial: 8829860
Drug: Granisetron 3
RxNorm normalized name: granisetron 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Granisetron 3 mg
Trial: 21496149
Drug: Subcutaneous insulin
RxNorm normalized name: subcutaneous insulin pump
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous insulin
Trial: 9064945
Drug: Quinaprilat (low
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quinaprilat (low dose: 0.5 and 1.0 mg, medium dose: 1.0 and 2.5 mg, high dose: 5.0 and 10.0 mg)
Trial: 1591513
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg i.v. cocaine injections
Trial: 8863695
Drug: Low-dose aspirin
RxNorm normalized name: low-dose aspirin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-dose aspirin (60 mg)
Trial: 28698321
Drug: oral oseltamivir
FDA approved: no
EMA approved: no
PMDA approved: no
Description: oral oseltamivir plus inhaled zanamivir (arm OZ)
Trial: 28698321
Drug: oral therapy
RxNorm normalized name: RelieVRx Virtual Reality Behavioral Therapy for Pain Relief
FDA approved: no
EMA approved: no
PMDA approved: no
Description: oral therapy
Trial: 28698321
Drug: inhaled therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: inhaled therapy
Trial: 28698321
Drug: antibiotic coprescriptions
FDA approved: no
EMA approved: no
PMDA approved: no
Description: antibiotic coprescriptions
Trial: 28698321
Drug: active combination
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: active combination treatment
Trial: 23406672
Drug: Sildenafil 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sildenafil 40 mg thrice daily
Trial: 17309402
Drug: High density
RxNorm normalized name: High density lipoprotein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High density lipoprotein cholesterol level < 1.0 mmol/L
Trial: 15121405
Drug: Olpadronate (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olpadronate (10 mg/m2 daily)
Trial: 31035354
Drug: Protein-fortified diet
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protein-fortified diet (1.8 g/kg/day)
Trial: 21741011
Drug: DTPa-IPV/Hib vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DTPa-IPV/Hib vaccine co-administered with hepatitis B vaccine
Trial: 17075318
Drug: Gemcitabine (1500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemcitabine (1500 mg/m) as a 30‐min intravenous infusion on days 1 and 8, followed by oxaliplatin (130 mg/m) as a 4‐h intravenous infusion on day 8 every 21 days
Trial: 7691117
Drug: Epirubicin 75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epirubicin 75 mg/m2 with G-CSF
Trial: 7691117
Drug: Epirubicin 60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epirubicin 60 mg/m2 without G-CSF
Trial: 7691117
Drug: Epirubicin 90
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epirubicin 90 mg/m2 with G-CSF
Trial: 6818829
Drug: Topical timolol
RxNorm normalized name: timolol
DrugBank: Timolol (DB00373)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Topical timolol with digital ocular compression
Trial: 6818829
Drug: Combined acetazolamide-mannitol
RxNorm normalized name: Acetazolamide
DrugBank: Acetazolamide (DB00819)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Combined acetazolamide-mannitol pre-medication with digital compression
Trial: 2817305
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no injections)
Trial: 1826962
Drug: etanidazole (2.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: etanidazole (2.0 g/m2) and pimonidazole (0.75 g/m2)
Trial: 1826962
Drug: etanidazole (2.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: etanidazole (2.0 g/m2/dose) and pimonidazole (0.75 g/m2)
Trial: 29566740
Drug: Filgotinib 50
RxNorm normalized name: nilotinib 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Filgotinib 50 mg
Trial: 21704239
Drug: CER 30
RxNorm normalized name: CER-001
DrugBank: CER-001 (DB18538)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CER 30 mg once daily
Trial: 21704239
Drug: CIR 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CIR 10 mg TID
Trial: 1592065
Drug: Caffeine (Caf)
RxNorm normalized name: Caffeine
DrugBank: Caffeine (DB00201)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Caffeine (Caf) 250 mg
Trial: 20575654
Drug: Natural progesterone
RxNorm normalized name: NATURAL PROGESTERONE CREAM,TOP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Natural progesterone (NP) per vagina at 100 mg/day